Lessons Learned in Designing Clinical Trials
Peter Mesenbrink of Novartis describes the challenges of designing clinical trials for effective COVID-19 treatment, and talks about the lessons learned in the process.
Peter Mesenbrink of Novartis describes the challenges of designing clinical trials for effective COVID-19 treatment, and talks about the lessons learned in the process.